HLA-I Antigen Presentation and Tapasin Influence Immune Responses Against Malignant Brain Tumors – Considerations for Successful Immunotherapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|14|8|1094-1100

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.8, 2014-10, pp. : 1094-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HLA class I antigen abnormalities and immune escape by malignant cells

By Seliger B. Cabrera T. Garrido F. Ferrone S.

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 3-13

Academic Press

Access to resources Recommend Favorite

Immune selective pressure and HLA class I antigen defects in malignant lesions

By Chang Chien-Chung Ferrone Soldano

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 2, 2007-02 ,pp. : 227-236

Springer Publishing Company

Access to resources Recommend Favorite

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy

By Ruiz-Cabello F. Cabrera T. Lopez-Nevot M-A. Garrido F.

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 403-405

Academic Press

Access to resources Recommend Favorite

Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors

By Chandramohan Vidyalakshmi Mitchell Duane A Johnson Laura A Sampson John H Bigner Darell D

Future Oncology, Vol. 9, Iss. 7, 2013-07 ,pp. : 977-990

Future Medicine

Access to resources Recommend Favorite

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma

By Naumova Elissaveta Mihaylova Anastassia Ivanova Milena Mihailova Snejina

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 1, 2007-01 ,pp. : 95-100

Springer Publishing Company

Access to resources Recommend Favorite